Product
Genetic elements to boost bioproduction
Technology boosting the cost-effective manufacturing of recombinant biopharmaceutical proteins by optimizing mammalian producer cells
ProteoNic
About
ProteoNic Biosciences is a privately held life sciences company offering premium vector technology substantially boosting the productivity of biopharmaceuticals, including biosimilars and difficult-to-express (DTE) proteins. The technology is compatible with all production cell lines and expression systems in the industry and its implementation does not require modifications to existing production systems or workflows. ProteoNic recently launched its 2G-UNic Transposon technology.
In the viral vector field, ProteoNic has the capacity and is further developing solutions to resolve bottlenecks associated with LV and AAV production.
ProteoNic is seeking R&D project cooperation in both fields, while offering the consortium production of recombinant biopharmaceutical proteins and/or improved elements to more efficiently generate new and better viral vectors.
ProteoNic has experience in National and EU grant projects.
Business Domain / 分野
Pharmaceuticals / 医薬品Foods / 食品Others /その他
Business Type / 業種
R&D / 研究開発Academia, Techtransfer / 学術、技術移転Others / その他
Disease Area / 疾患領域
Oncology / がんImmunology / 免疫・炎症Rare diseases / 希少疾患Others / その他
Modalities / モダリティ
Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Gene therapy /遺伝子治療Cell therapy /細胞治療Others /その他
Technologies / 技術
Drug synthesis / 医薬品合成Pharmaceutical ingredients / 医薬品原料Others / その他
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等（共同での研究、開発を目的）Major pharma etc. (Out-licensing purpose) / 大手ファーマ等（アウトライセンスを目的）Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等（インライセンス、共同研究などを目的）Companies and Entities (Providing your services or technology to your clients) / 技術・サービス（研究、開発、製造等の提供を目的）CROs, CMOs, CDMOs, etc. (Partnerships)/CRO、CMO、CDMO等（インライセンス、共同研究などを目的）AI-focused companies etc. (Partnership/Collaboration about AI solutions) / AIによるソリューションをもつ企業等（インライセンス、共同研究などを目的）Others
Researched disease area / マッチングご希望の疾患領域
Oncology / がんNeurology & Psychiatryy / 中枢神経、精神疾患Infectious diseases / 感染症Immunology / 免疫・炎症Rare diseases / 希少疾患Others /その他
Researched Modality / マッチングご希望のモダリティ
Peptide, Protein / ペプチド、タンパクAntibody drug / 抗体医薬Gene therapy/ 遺伝子治療Cell therapy / 細胞治療Others / その他
Researched Technologies / マッチングご希望の技術
Biomarkers / バイオマーカーAI・Data analysis/ AI・データ分析Genetic analysis / 遺伝子診断Others /その他
Marketplace (3)
Project cooperation
Development of new recombinant biopharmaceutical proteins and their cost-effective production by optimizing mammalian producer cells
- Planning
- Research
- Technical
- Financing
Project cooperation
Advancing disease treatment through innovations in viral vector based gene therapy
ProteoNic seeks Partners in need to develop new gene therapy product and/or a cost-efficient broadly applicable gene therapy method.